Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Not sure whether to like or dislike this line

Thanks for the claification.  Hopefully, PTSC's estimate was based on the original 150 or so "on-notice" companies, which if now in the 485 range that you inidicate would increase the portfolio value proportionally to $3.2B and the average per license to $6.6M.

I like those number MUCH BETTER!

Share
New Message
Please login to post a reply